Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1985 Feb;75(2):650–656. doi: 10.1172/JCI111743

Immunoregulatory T cells in man. Histamine-induced suppressor T cells are derived from a Leu 2+ (T8+) subpopulation distinct from that which gives rise to cytotoxic T cells.

P Sansoni, E D Silverman, M M Khan, K L Melmon, E G Engleman
PMCID: PMC423548  PMID: 3156150

Abstract

One mechanism of histamine-mediated inhibition of the immune response in man is to activate T suppressor cells that bear the Leu 2 (OKT8) marker. The current study was undertaken to characterize the histamine-induced suppressor cell using a monoclonal antibody (9.3) shown previously to distinguish cytotoxic T cells from antigen-specific suppressor T cells. Leu 2+ cells isolated from peripheral blood were further separated with antibody 9.3 into Leu 2+, 9.3+, and Leu 2+, 9.3- subsets and each subset was incubated with different concentrations of histamine before determining their ability to suppress immune responses in vitro. The results indicate that the Leu 2+, 9.3- subpopulation includes all histamine-induced suppressor cells, that 10(-4) M histamine is the optimal concentration for suppressor cell induction, and that exposure of Leu 2+, 9.3- cells to histamine for 30 s is sufficient to initiate the induction process. After treatment with histamine these cells inhibit both phytohemagglutinin-induced T cell proliferation and pokeweed mitogen-induced B cell differentiation. The suppression of phytohemagglutinin-induced proliferation was resistant to x-irradiation with 1,200 rad, either before or after histamine exposure, suggesting that Leu 2+, 9.3- cells need not proliferate to become suppressor cells or exert suppression. Moreover, suppression by these cells was not due to altered kinetics of the response. Finally, a histamine type 2 receptor antagonist (cimetidine) but not a type 1 receptor antagonist (mepyramine) blocked the induction of suppressor cells. On the basis of these results and our previous studies of antigen specific suppressor cells, we conclude that Leu 2+ suppressor cells in man are derived from a precursor pool that is phenotypically distinct from cells that can differentiate into cytotoxic T cells.

Full text

PDF
650

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Badger A. M., Young J., Poste G. Inhibition of phytohaemagglutinin-induced proliferation of human peripheral blood lymphocytes by histamine and histamine H1 and H2 agonists. Clin Exp Immunol. 1983 Jan;51(1):178–184. [PMC free article] [PubMed] [Google Scholar]
  2. Bourne H. R., Lichtenstein L. M., Melmon K. L., Henney C. S., Weinstein Y., Shearer G. M. Modulation of inflammation and immunity by cyclic AMP. Science. 1974 Apr 5;184(4132):19–28. doi: 10.1126/science.184.4132.19. [DOI] [PubMed] [Google Scholar]
  3. Bristow M. R., Cubicciotti R., Ginsburg R., Stinson E. B., Johnson C. Histamine-mediated adenylate cyclase stimulation in human myocardium. Mol Pharmacol. 1982 May;21(3):671–679. [PubMed] [Google Scholar]
  4. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  5. Damle N. K., Engleman E. G. Immunoregulatory T cell circuits in man. Alloantigen-primed inducer T cells activate alloantigen-specific suppressor T cells in the absence of the initial antigenic stimulus. J Exp Med. 1983 Jul 1;158(1):159–173. doi: 10.1084/jem.158.1.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Damle N. K., Mohagheghpour N., Engleman E. G. Soluble antigen-primed inducer T cells activate antigen-specific suppressor T cells in the absence of antigen-pulsed accessory cells: phenotypic definition of suppressor-inducer and suppressor-effector cells. J Immunol. 1984 Feb;132(2):644–650. [PubMed] [Google Scholar]
  7. Damle N. K., Mohagheghpour N., Hansen J. A., Engleman E. G. Alloantigen-specific cytotoxic and suppressor T lymphocytes are derived from phenotypically distinct precursors. J Immunol. 1983 Nov;131(5):2296–2300. [PubMed] [Google Scholar]
  8. De Cock W., De Cree J., Verhaegen H. Histamine receptor-bearing T lymphocytes in patients with allergy, autoimmune disease, or recurrent infection. Clin Immunol Immunopathol. 1978 Sep;11(1):1–5. doi: 10.1016/0090-1229(78)90198-8. [DOI] [PubMed] [Google Scholar]
  9. Evans R. L., Wall D. W., Platsoucas C. D., Siegal F. P., Fikrig S. M., Testa C. M., Good R. A. Thymus-dependent membrane antigens in man: inhibition of cell-mediated lympholysis by monoclonal antibodies to TH2 antigen. Proc Natl Acad Sci U S A. 1981 Jan;78(1):544–548. doi: 10.1073/pnas.78.1.544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Garovoy M. R., Reddish M. A., Rocklin R. E. Histamine-induced suppressor factor (HSF): inhibition of helper T cell generation and function. J Immunol. 1983 Jan;130(1):357–361. [PubMed] [Google Scholar]
  11. Gatenby P. A., Kotzin B. L., Engleman E. G. Induction of immunoglobulin secreting cells in the human autologous mixed leukocyte reaction: regulation by helper and suppressor lymphocyte subsets defined with monoclonal antibodies. J Immunol. 1981 Nov;127(5):2130–2135. [PubMed] [Google Scholar]
  12. Gronowicz E., Coutinho A., Melchers F. A plaque assay for all cells secreting Ig of a given type or class. Eur J Immunol. 1976 Aug;6(8):588–590. doi: 10.1002/eji.1830060812. [DOI] [PubMed] [Google Scholar]
  13. Jorizzo J. L., Sams W. M., Jr, Jegasothy B. V., Olansky A. J. Cimetidine as an immunomodulator: chronic mucocutaneous candidiasis as a model. Ann Intern Med. 1980 Feb;92(2 Pt 1):192–195. doi: 10.7326/0003-4819-92-2-192. [DOI] [PubMed] [Google Scholar]
  14. Kotzin B. L., Benike C. J., Engleman E. G. Induction of immunoglobulin-secreting cells in the allogeneic mixed leukocyte reaction: regulation by helper and suppressor lymphocyte subsets in man. J Immunol. 1981 Sep;127(3):931–935. [PubMed] [Google Scholar]
  15. Lima M., Rocklin R. E. Histamine modulates in vitro IgG production by pokeweed mitogen-stimulated human mononuclear cells. Cell Immunol. 1981 Nov 1;64(2):324–336. doi: 10.1016/0008-8749(81)90484-6. [DOI] [PubMed] [Google Scholar]
  16. Melmon K. L., Bourne H. R., Weinstein Y., Shearer G. M., Kram J., Bauminger S. Hemolytic plaque formation by leukocytes in vitro. Control by vasoactive hormones. J Clin Invest. 1974 Jan;53(1):13–21. doi: 10.1172/JCI107530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Osband M. E., Lipton J. M., Lavin P., Levey R., Vawter G., Greenberger J. S., McCaffrey R. P., Parkman R. Histiocytosis-X. N Engl J Med. 1981 Jan 15;304(3):146–153. doi: 10.1056/NEJM198101153040304. [DOI] [PubMed] [Google Scholar]
  18. Plaut M., Lichtenstein L. M., Gillespie E., Henney C. S. Studies on the mechanism of lymphocyte-mediated cytolysis. IV. Specificity of the histamine receptor on effector T cells. J Immunol. 1973 Aug;111(2):389–394. [PubMed] [Google Scholar]
  19. Plaut M., Lichtenstein L. M., Henney C. S. Increase in histamine receptors on thymus-derived effector lymphocytes during the primary immune response to alloantigens. Nature. 1973 Aug 3;244(5414):284–287. doi: 10.1038/244284a0. [DOI] [PubMed] [Google Scholar]
  20. Plaut M., Lichtenstein L. M., Henney C. S. Properties of a subpopulation of T cells bearing histamine receptors. J Clin Invest. 1975 Apr;55(4):856–874. doi: 10.1172/JCI107997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Primack W. A. Cimetidine and renal-allograft rejection. Lancet. 1978 Apr 15;1(8068):824–825. doi: 10.1016/s0140-6736(78)93025-8. [DOI] [PubMed] [Google Scholar]
  22. Reinherz E. L., Kung P. C., Goldstein G., Schlossman S. F. A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2. J Immunol. 1980 Mar;124(3):1301–1307. [PubMed] [Google Scholar]
  23. Reinherz E. L., Kung P. C., Goldstein G., Schlossman S. F. Separation of functional subsets of human T cells by a monoclonal antibody. Proc Natl Acad Sci U S A. 1979 Aug;76(8):4061–4065. doi: 10.1073/pnas.76.8.4061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Reinherz E. L., Schlossman S. F. The differentiation and function of human T lymphocytes. Cell. 1980 Apr;19(4):821–827. doi: 10.1016/0092-8674(80)90072-0. [DOI] [PubMed] [Google Scholar]
  25. Rocklin R. E., Breard J., Gupta S., Good R. A., Melmon K. L. Characterization of the human blood lymphocytes that produce a histamine-induced suppressor factor (HSF). Cell Immunol. 1980 May;51(2):226–237. doi: 10.1016/0008-8749(80)90255-5. [DOI] [PubMed] [Google Scholar]
  26. Rocklin R. E. Modulation of cellular-immune responses in vivo and in vitro by histamine receptor-bearing lymphocytes. J Clin Invest. 1976 Apr;57(4):1051–1058. doi: 10.1172/JCI108347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Rocklin R. E., Sheffer A. L., Greineder D. K., Melmon K. L. Generation of antigen-specific suppressor cells during allergy desensitization. N Engl J Med. 1980 May 29;302(22):1213–1219. doi: 10.1056/NEJM198005293022201. [DOI] [PubMed] [Google Scholar]
  28. Saxon A., Feldhaus J., Robins R. A. Single step separation of human T and B cells using AET treated srbc rosettes. J Immunol Methods. 1976;12(3-4):285–288. doi: 10.1016/0022-1759(76)90050-8. [DOI] [PubMed] [Google Scholar]
  29. Schwartz A., Askenase P. W., Gershon R. K. Histamine inhibition of the in vitro induction of cytotoxic T-cell responses. Immunopharmacology. 1980 Jun;2(3):179–190. doi: 10.1016/0162-3109(80)90048-x. [DOI] [PubMed] [Google Scholar]
  30. Thomas Y., Huchet R., Granjon D. Histamine-induced suppressor cells of lymphocyte mitogenic response. Cell Immunol. 1981 Apr;59(2):268–275. doi: 10.1016/0008-8749(81)90408-1. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES